U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07665229) titled 'VOCAL BIOMARKERS FOR HEALTH MONITORING: AN OPEN LONGITUDINAL HYBRID COHORT STUDY' on Feb. 11.
Brief Summary: Voice could be considered a new vital sign in the future, being collected in routine care and complement other medical assessments.
Vocal biomarkers (VB) are voice characteristics that are specific to a disease or symptom. They can be utilized in clinical practice for remote disease monitoring, screening for diseases, or in clinical research as secondary endpoints to evaluate the efficacy of a treatment or intervention. They can also be used during enhanced consultations to screen for diseases or monitor the progression of a...